The Renin–Angiotensin System Modulates SARS-CoV-2 Entry via ACE2 Receptor

The Renin–Angiotensin System Modulates SARS-CoV-2 Entry via ACE2 Receptor

The renin–angiotensin system (RAS) plays a central role in cardiovascular regulation and has gained prominence in the pathogenesis of Coronavirus Disease 2019 (COVID-19) due to the critical function of angiotensin-converting enzyme 2 (ACE2) as the entry receptor for severe acute respiratory syndrome...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sophia Gagliardi, Tristan Hotchkin, Hasset Tibebe, Grace Hillmer, Dacia Marquez, Coco Izumi, Jason Chang, Alexander Diggs, Jiro Ezaki, Yuichiro J. Suzuki, Taisuke Izumi
Format:	Article
Language:	English
Published:	MDPI AG 2025-07-01
Series:	Viruses
Subjects:	angiotensin renin–angiotensin system angiotensin-converting enzyme 2 severe acute respiratory syndrome coronavirus 2 spike protein viral-like particle
Online Access:	https://www.mdpi.com/1999-4915/17/7/1014
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The role of renin-angiotensin system and angiotensin-converting enzyme 2 (ACE2) in the development and course of viral infection COVID-19 in patients with diabetes mellitus
by: O. K. Vikulova, et al.
Published: (2020-08-01)

The role of the classical renin–angiotensin system and angiotensin-converting enzyme 2/Ang(1–7)/Mas axis in pulmonary fibrosis
by: Changhui Lang, et al.
Published: (2025-07-01)

Renin–angiotensin system inhibition in COVID-19 patients: Friend or foe?
by: Bilgehan Karadağ
Published: (2020-07-01)

RENIN-ANGIOTENSIN SYSTEM IN REGULATION OF HEMATOPOIESIS
by: M. L. Kanaeva, et al.
Published: (2018-02-01)

Modulation of the renin-angiotensin system against COVID-19: A path forward?
by: Serge Camelo, et al.
Published: (2025-05-01)

EFFECTS OF VITAMIN D ON THE RENIN-ANGIOTENSIN SYSTEM
by: L. Pashova-Stoyanova, et al.
Published: (2019-09-01)

LONG-TERM EFFECTS OF OLMESARTAN, AN ANG II RECEPTOR ANTAGONIST, ON BLOOD PRESSURE AND THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: Shuichi Ichikawa, et al.
Published: (2011-06-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
by: O. M. Drapkina, et al.
Published: (2014-07-01)

Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension
by: Juan Meng, et al.
Published: (2020-01-01)

Angiotensins and rheumatoid arthritis
by: N. M. Savushkina, et al.
Published: (2019-01-01)

Left ventricular hypertrophy: renin4angiotensin system role
by: F. T. Ageev, et al.
Published: (2008-04-01)

MECHANISMS OF COMBINED ACTION OF ACE INHIBITORS AND CALCIUM ANTAGONISTS IN ARTERIAL HYPERTENSION
by: E. I. Astashkin, et al.
Published: (2013-06-01)

THE RENIN-ANGIOTENSIN SYSTEM AND ITS INVOLVEMENT IN PAIN CONTROL. A NEW INSIGHT INTO AN OLD SYSTEM
by: Daniela Pechlivanova, et al.
Published: (2025-04-01)

The systemic angiotensin-II role in the development of retinopathy of prematurity
by: N. A. Osipova, et al.
Published: (2023-07-01)

Duration of rheumatoid arthritis changes blood levels of angiotensin and aldosterone
by: Boris A. Rebrov, et al.
Published: (2023-12-01)

Angiotensin II type 1 receptor antagonists and ACE inhibitors in the regulation of hemodynamics and renin-angiotensin-aldosterone system activity: focus on the organ protection
by: M. L. Maksimov, et al.
Published: (2010-04-01)

Novel Antihypertensive Medications to Target the Renin-Angiotensin System: Mechanisms and Research
by: Zhe Jiang, et al.
Published: (2025-04-01)

RAA System and Exercise Relationship
by: Sadettin Ünsal, et al.
Published: (2019-09-01)

Myocardial and Renal Renin–Angiotensin System Enzyme Activity in Dogs
by: Emma C. Weitzhandler, et al.
Published: (2025-07-01)

Crosstalk between renin and arachidonic acid (and its metabolites)
by: Undurti N. Das, et al.
Published: (2025-02-01)

View on the problem of diabetic nephropathy in children and adolescents with type 1 diabetes: the role of renin-angiotensin-aldosterone system (literature review) (part 2)
by: K. V. Skobeleva, et al.
Published: (2021-06-01)

The renin-angiotensin system in healthy human platelets: expressed but inactive
by: François Panosetti, et al.
Published: (2025-12-01)

ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASE: WHAT TO CHOOSE?
by: K. A. Ghyamdzhyan, et al.
Published: (2012-09-01)

ANGIOTENSIN II RECEPTOR TYPE 1 EXPRESSION IN PATIENTS WITH MULTIFOCAL ATHEROSCLEROSIS
by: I. S. Mykhailichenko
Published: (2016-04-01)

Comparison of angiotensin converting enzyme 1 levels to the grading of knee osteoarthritis
by: Fidelia Elvira Da Costa Rao, et al.
Published: (2024-06-01)

ELABELA Ameliorates Atherosclerosis Through Restoring the M1/M2 Macrophage Balance in ApoE−/− Mice
by: Le Tang, et al.
Published: (2025-07-01)

Dynamics of renin-angiotensin-aldosteron system and lipid profile in hypertensive hypothyrosis patients during the process of thyroid function compensation
by: P. Kh. Dzhanashiya, et al.
Published: (2004-12-01)

View on the problem of diabetic nephropathy in children and adolescents with type 1 diabetes mellitus: the role of renin-angiotensin-aldosterone system (literature review) (part 1)
by: K. V. Skobeleva, et al.
Published: (2021-06-01)

ACE2 and ANGII levels in patients with COVID-19 based on thoracic tomography findings and PCR test results
by: Afsin Ipekci, et al.
Published: (2022-03-01)

RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND REPLICATIVE CELLULAR SENESCENCE: THEIR INTERACTION DURING THE VASCULAR AGEING
by: V. S. Pykhtina, et al.
Published: (2015-09-01)

Prospects of using genetic testing to increase the effectiveness of antihypertensive therapy
by: N. V. Drobotya, et al.
Published: (2020-06-01)

Angiotensin II and Cardiovascular Disease: Balancing Pathogenic and Protective Pathways
by: Ulvi Bayraktutan
Published: (2025-07-01)

Patiromer to Reduce Albuminuria Through Increased Renin Angiotensin Aldosterone System Inhibition in Patients With CKD-A Feasibility Trial
by: Frederik H. Mårup, et al.
Published: (2024-08-01)

Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19
by: Naci Şenkal, et al.
Published: (2020-07-01)

Optimization of Renin-Angiotensin-Aldosterone Inhibitor Therapies for Evidence-Based Indications: a Call to Action From the Cardio-Kidney Community
by: Roberto Pecoits-Filho, MD, PhD, et al.
Published: (2025-07-01)

Association of Plasma Renin Activity with Risk of Late Hypertension in Pediatric Patients with Early Aortic Coarctation Repair: A Retrospective Study
by: Irina-Maria Margarint, et al.
Published: (2025-04-01)

Pharmacogenetic aspects of eprosartan therapy and polymorphic markers of renin-angiotensin-aldosterone system genes in Uzbek patients with essential arterial hypertension
by: D. R. Kurbanova, et al.
Published: (2009-06-01)

Comparison of clinical outcomes between angiotensin-converting-enzyme inhibitors and ARBs in patients with acute myocardial infarction with dyslipidemia after a successful stent implantation
by: Yong Hoon Kim, et al.
Published: (2020-01-01)

Revisiting the renin-angiotensin-aldosterone system in the eye: Mechanistic insights and pharmacological targets
by: Francesco Buonfiglio, et al.
Published: (2025-06-01)

Direct renin inhibitor aliskiren in women with menopausal metabolic syndrome and arterial hypertension
by: Yu. V. Zhernakova, et al.
Published: (2011-08-01)